Per ProHealth's published guarantee terms, the company offers a 100-day money-back guarantee on its products
This remains an actively moving area, however: on February 27, 2026, the HHS Secretary publicly announced an intent to move roughly 14 of the 19 Category 2-listed peptides, reportedly including ipamorelin and CJC-1295, back toward Category 1 status, and multiple industry and legal-news outlets reported further FDA action in the following months easing Category 2-related restrictions on this group of peptides
Remove thoroughly
References Gwyer, D., Wragg, N
Possible side effects and precautions Gastrointestinal issues are common with liraglutide, especially early in the dose-escalation process
The landmark Rudman study demonstrated that GH restoration in older men produced significant improvements in lean mass, fat mass, and skin thickness (9)